ArticleJournal of pharmacokinetics and pharmacodynamics2024

Virtual clinical trials via a QSP immuno-oncology model to simulate the response to a conditionally activated PD-L1 targeting antibody in NSCLC.

Alberto Ippolito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.